FR186M - New drug in particular for the treatment of inflammatory reactions of toxic or infectious rheumatic origin. - Google Patents

New drug in particular for the treatment of inflammatory reactions of toxic or infectious rheumatic origin.

Info

Publication number
FR186M
FR186M FR835800A FR835800A FR186M FR 186 M FR186 M FR 186M FR 835800 A FR835800 A FR 835800A FR 835800 A FR835800 A FR 835800A FR 186 M FR186 M FR 186M
Authority
FR
France
Prior art keywords
infectious
toxic
treatment
new drug
inflammatory reactions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR835800A
Other languages
French (fr)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Laboratoires Francais de Chimiotherapie SA
Original Assignee
Laboratoires Francais de Chimiotherapie SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratoires Francais de Chimiotherapie SA filed Critical Laboratoires Francais de Chimiotherapie SA
Priority to FR835800A priority Critical patent/FR186M/en
Application granted granted Critical
Publication of FR186M publication Critical patent/FR186M/en
Active legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20Oxygen atoms
    • C07D215/22Oxygen atoms attached in position 2 or 4
    • C07D215/227Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 2
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D221/00Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/04Ortho- or peri-condensed ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D455/00Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D455/00Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine
    • C07D455/03Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing quinolizine ring systems directly condensed with at least one six-membered carbocyclic ring, e.g. protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine
    • C07D455/04Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing quinolizine ring systems directly condensed with at least one six-membered carbocyclic ring, e.g. protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing a quinolizine ring system condensed with only one six-membered carbocyclic ring, e.g. julolidine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J5/00Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J75/00Processes for the preparation of steroids in general
FR835800A 1960-08-12 1960-08-12 New drug in particular for the treatment of inflammatory reactions of toxic or infectious rheumatic origin. Active FR186M (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR835800A FR186M (en) 1960-08-12 1960-08-12 New drug in particular for the treatment of inflammatory reactions of toxic or infectious rheumatic origin.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR835800A FR186M (en) 1960-08-12 1960-08-12 New drug in particular for the treatment of inflammatory reactions of toxic or infectious rheumatic origin.

Publications (1)

Publication Number Publication Date
FR186M true FR186M (en) 1961-02-20

Family

ID=88586608

Family Applications (1)

Application Number Title Priority Date Filing Date
FR835800A Active FR186M (en) 1960-08-12 1960-08-12 New drug in particular for the treatment of inflammatory reactions of toxic or infectious rheumatic origin.

Country Status (1)

Country Link
FR (1) FR186M (en)

Similar Documents

Publication Publication Date Title
FR1009M (en) Medicine for the treatment of angina pectoris.
FR1187M (en) New drug in particular for the treatment of inflammatory manifestations of arthritic or infectious rheumatic origin.
FR1438M (en) New drug effective in the treatment of atherosclerosis.
FR3244M (en) New drug in particular for the treatment of inflammatory manifestations of rheumatic, arthritic or infectious origin.
FR186M (en) New drug in particular for the treatment of inflammatory reactions of toxic or infectious rheumatic origin.
FR37M (en) New drug in particular for the treatment of inflammatory phenomena of rheumatic, arthritic or hepatic origin.
FR342M (en) New tri-hydroxylated steroid drug, in particular for the treatment of spasms of coronary origin.
FR151M (en) New drug, in particular for the treatment of neuro-depressive states and anxiety psychoses.
FR2929M (en) Pharmaceutical composition for the treatment of arthritic and rheumatic conditions.
FR16M (en) New drug in particular for the treatment of inflammatory phenomena of rheumatic, arthritic or hepatic origin.
FR3395M (en) New drug, in particular for the treatment of neurodepressive states and anxiety psychoses.
BE612141Q (en) New drugs in particular for the treatment of spasms of coronary origin.
FR1764M (en) New drug in particular for the treatment of spasms of coronary or visceral origin.
FR3316M (en) New drug in particular for the treatment of inflammatory manifestations of rheumatic, arthritic or infectious origin.
FR385M (en) New drug for the treatment of staphylococcal infections and the like.
FR2810M (en) New drug in particular for the treatment of spasms of coronary or visceral origin.
FR3419M (en) New drugs, in particular for the treatment of neuro-depressive states and anxiety psychoses.
FR1635M (en) New drug in particular for the treatment of spasms of coronary origin.
FR1141M (en) New drug in particular for the treatment of spasms of coronary origin.
FR1804M (en) New drug in particular for the treatment of infections of microbial origin.
FR1484M (en) New drug in particular for the treatment of inflammatory manifestations of microbial origin.
FR33F (en) New drug for the treatment of staphylococcal infections and the like.
FR153M (en) New isopropylated drug, in particular for the treatment of neurodepressive states and anxiety psychoses.
FR2603M (en) New drug in particular for the treatment of hepatic degenerations of chemical, bacterial, toxic or senile origin.
FR2681M (en) New drug in particular for the treatment of spasms of coronary origin.